Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Ouzan

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Gastroenterologie Clinique Et Biologique|May 22, 2003
[Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district]Denis Ouzan, Philippe Cavailler, Philippe Hofliger, et al.
Journal of Medical Virology|December 24, 2005
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infectionPhilippe Halfon, Guillaume Pénaranda, Marc Bourlière, et al.
European Journal of Gastroenterology & Hepatology|September 23, 2003
Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete responsePhilippe Halfon, Hacene Khiri, Albert Tran, et al.
Dermatology (Basel, Switzerland)|April 4, 2003
Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern FranceChristine Chiavérini, Gilles Halimi, Denis Ouzan, et al.
European Journal of Gastroenterology & Hepatology|December 30, 2021
Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver diseaseDenis Ouzan, Anne Mosnier, Guillaume Penaranda, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Therapeutic Advances in Gastroenterology|July 3, 2020
Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinomaAngélique Saint, Maxime Benchetrit, Sébastien Novellas, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2010
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort studyPascal Melin, Michel Chousterman, Thierry Fontanges, et al.
Antiviral Therapy|July 1, 2010
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort studyJean-Philippe Lang, Pascal Melin, Denis Ouzan, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Gastroenterologie Clinique Et Biologique|May 22, 2003
[Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district]Denis Ouzan, Philippe Cavailler, Philippe Hofliger, et al.
Journal of Medical Virology|December 24, 2005
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infectionPhilippe Halfon, Guillaume Pénaranda, Marc Bourlière, et al.
European Journal of Gastroenterology & Hepatology|September 23, 2003
Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete responsePhilippe Halfon, Hacene Khiri, Albert Tran, et al.
Dermatology (Basel, Switzerland)|April 4, 2003
Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern FranceChristine Chiavérini, Gilles Halimi, Denis Ouzan, et al.
European Journal of Gastroenterology & Hepatology|December 30, 2021
Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver diseaseDenis Ouzan, Anne Mosnier, Guillaume Penaranda, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Therapeutic Advances in Gastroenterology|July 3, 2020
Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinomaAngélique Saint, Maxime Benchetrit, Sébastien Novellas, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2010
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort studyPascal Melin, Michel Chousterman, Thierry Fontanges, et al.
Antiviral Therapy|July 1, 2010
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort studyJean-Philippe Lang, Pascal Melin, Denis Ouzan, et al.
Pageof 7